Parmveer Singh

1.1k total citations
8 papers, 97 citations indexed

About

Parmveer Singh is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Parmveer Singh has authored 8 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Parmveer Singh's work include Prostate Cancer Treatment and Research (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). Parmveer Singh is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). Parmveer Singh collaborates with scholars based in United Kingdom, United States and Canada. Parmveer Singh's co-authors include Heather E. McDermid, David M. Irwin, Étienne Audinat, Christian Steinhäuser, Michael T. Heneka, Peter Bedner, Gerald Seifert, Adriana Buskin, Rakesh Heer and Frederic Brosseron and has published in prestigious journals such as Blood, PLoS ONE and Development.

In The Last Decade

Parmveer Singh

7 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Parmveer Singh United Kingdom	5	42	21	18	16	15	8	97
Tong Hong Yeo Singapore	5	36 0.9×	18 0.9×	14 0.8×	28 1.8×	6 0.4×	12	136
Marion I. Stunault United States	5	59 1.4×	37 1.8×	6 0.3×	7 0.4×	8 0.5×	8	145
Christopher Uy Canada	6	62 1.5×	16 0.8×	11 0.6×	4 0.3×	21 1.4×	14	238
Charlotte Van den Eynde Belgium	8	68 1.6×	11 0.5×	23 1.3×	10 0.6×	7 0.5×	10	186
Maysoon Alsagob Saudi Arabia	6	62 1.5×	15 0.7×	12 0.7×	6 0.4×	7 0.5×	12	109
Michael Nissen Australia	5	31 0.7×	23 1.1×	10 0.6×	19 1.2×	53 3.5×	8	157
Natalya Karp Canada	8	53 1.3×	11 0.5×	8 0.4×	8 0.5×	5 0.3×	14	134
Deepa Krishnakumar United Kingdom	7	65 1.5×	20 1.0×	6 0.3×	7 0.4×	9 0.6×	15	187
Yuichiro Gondo Japan	5	22 0.5×	13 0.6×	7 0.4×	45 2.8×	18 1.2×	6	119

Countries citing papers authored by Parmveer Singh

Since Specialization

Citations

This map shows the geographic impact of Parmveer Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parmveer Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parmveer Singh more than expected).

Fields of papers citing papers by Parmveer Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parmveer Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parmveer Singh. The network helps show where Parmveer Singh may publish in the future.

Co-authorship network of co-authors of Parmveer Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Parmveer Singh. A scholar is included among the top collaborators of Parmveer Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parmveer Singh. Parmveer Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Matusow, Bernice, Sadegh Saghafinia, Panyu Chen, et al.. (2024). OPN-6602, an Orally Bioavailable EP300/CBP Bromodomain Inhibitor, Targets Multiple Myeloma through Suppression of IRF4 and MYC. Blood. 144(Supplement 1). 1908–1908. 1 indexed citations

Matusow, Bernice, Wayne Spevak, Yan Ma, et al.. (2024). Abstract 660: OPN-6602, a potent dual EP300/CBP bromodomain inhibitor, targets multiple myeloma through concomitant suppression of IRF4 and c-MYC. Cancer Research. 84(6_Supplement). 660–660.

Singh, Parmveer, Nadia A. Lanman, Laura Wilson, et al.. (2023). Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. Development. 150(13). 1 indexed citations

Müller, Julia, Gerald Seifert, Étienne Audinat, et al.. (2022). Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsy. Glia. 71(2). 168–186. 37 indexed citations

Buskin, Adriana, et al.. (2021). A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease. International Journal of Molecular Sciences. 22(23). 13097–13097. 7 indexed citations

Hepburn, Anastasia C., Mohammad Moad, Rebecca E. Steele, et al.. (2020). Propagation of human prostate tissue from induced pluripotent stem cells. Stem Cells Translational Medicine. 9(7). 734–745. 27 indexed citations

Singh, Parmveer & David M. Irwin. (2016). Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes. PLoS ONE. 11(2). e0149682–e0149682. 7 indexed citations

Singh, Parmveer, et al.. (2016). Genetic backgrounds and modifier genes of NTD mouse models: An opportunity for greater understanding of the multifactorial etiology of neural tube defects. Birth Defects Research. 109(2). 140–152. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact